Evaluation of the effect of oral monte locust in the treatment of acute asthma in childre
Phase 3
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT20200412047048N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All patients aged 1-14 years who are confirmed based on history and examination for asthma attack
Exclusion Criteria
Those with a history of taking corticosteroids or montelukast for the past ten days
All patients who developed a diagnosis other than asthma, such as pneumonia or bronchiolitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asthma. Timepoint: At the beginning of the patient's visit, 1,4,8,24,48 hours after the intervention and one week after discharge from the hospital. Method of measurement: Patient scoreboard.
- Secondary Outcome Measures
Name Time Method